U.S. Top Stock Picks from Analysts

JD.com

Market Cap: US$47.1b

Operates as a supply chain-based technology and service provider in the People’s Republic of China.

Centene

Market Cap: US$28.2b

Operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, and commercial organizations in the United States.

Molina Healthcare

Market Cap: US$16.6b

Provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces.

JBS

Market Cap: US$15.8b

Operates as a protein and food company worldwide.

Summit Therapeutics

Market Cap: US$15.7b

A biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies.

QXO

Market Cap: US$14.2b

Distributes roofing, waterproofing, and other building products in the United States.

Moderna

Market Cap: US$11.1b

A biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.

BioMarin Pharmaceutical

Market Cap: US$10.8b

A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.

Aurora Innovation

Market Cap: US$8.9b

Operates as a self-driving technology company in the United States.

VinFast Auto

Market Cap: US$8.3b

Engages in the design and manufacture of electric vehicles (EV), e-scooters, and e-buses in Vietnam, Canada, and the United States.

Roivant Sciences

Market Cap: US$7.4b

A clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies.

Corcept Therapeutics

Market Cap: US$7.3b

Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

Revolution Medicines

Market Cap: US$6.9b

A clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers.

Legend Biotech

Market Cap: US$6.7b

Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.

Jazz Pharmaceuticals

Market Cap: US$6.6b

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.

ZEEKR Intelligent Technology Holding

Market Cap: US$6.5b

An investment holding company, engages in the research and development, production, commercialization, and sale of the electric vehicles and batteries.

Lantheus Holdings

Market Cap: US$5.5b

Develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide.

Axsome Therapeutics

Market Cap: US$5.1b

A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.

ChampionX

Market Cap: US$5.0b

Provides chemistry solutions, artificial lift systems, and engineered equipment and technologies to oil and gas companies worldwide.

Chagee Holdings

Market Cap: US$4.9b

Through its subsidiaries, owns, operates, and franchises teahouses under the CHAGEE brand name in the People’s Republic of China and internationally.

Pony AI

Market Cap: US$4.7b

Through its subsidiaries, engages in the autonomous mobility business in the People’s Republic of China, the United States, and internationally.

CRISPR Therapeutics

Market Cap: US$4.5b

A gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform.

ADMA Biologics

Market Cap: US$4.3b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

Vaxcyte

Market Cap: US$4.2b

A clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.

Globant

Market Cap: US$4.1b

Provides technology services worldwide.

Cytokinetics

Market Cap: US$4.0b

A late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases in the United States.

Merus

Market Cap: US$3.9b

A clinical-stage immuno-oncology company, engages in the development of antibody therapeutics in the Netherlands.

Zai Lab

Market Cap: US$3.9b

A biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.

Inspire Medical Systems

Market Cap: US$3.9b

A medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally.

Cellebrite DI

Market Cap: US$3.8b

Develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific.

Remitly Global

Market Cap: US$3.8b

Engages in the provision of digital financial services in the United States, Canada, and internationally.

Zeta Global Holdings

Market Cap: US$3.6b

Operates an omnichannel data-driven cloud platform that provides enterprises with consumer intelligence and marketing automation software in the United States and internationally.

Arcellx

Market Cap: US$3.6b

Together with its subsidiary, engages in the development of various immunotherapies for patients with cancer and other incurable diseases in the United States.

Avidity Biosciences

Market Cap: US$3.5b

A biopharmaceutical company, engages in the delivery of RNA therapeutics called antibody oligonucleotide conjugates (AOCs).

Freshpet

Market Cap: US$3.5b

Manufactures, distributes, and markets natural fresh meals and treats for dogs and cats in the United States, Canada, and Europe.

Ultragenyx Pharmaceutical

Market Cap: US$3.4b

A biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Latin America, Europe, the Middle East, Africa, and the Asia-Pacific.